Main Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Main Management’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5	Closed	-$1K	–	146
2024 Q2	$1K	Buy	+5	New	+$535	﹤0.01%	141
2023 Q3	–	Sell	-5	Closed	-$1K	–	135
2023 Q2	$1K	Hold	5	–	–	﹤0.01%	127
2023 Q1	$0	Hold	5	–	–	﹤0.01%	133
2022 Q4	$1K	Buy	+5	New	+$697	﹤0.01%	127

Other funds holding LABU

Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

TAA

TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return

Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Main Management's LABU Position: Q3 2024 in Review

Main Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2024, closing a stake of 5 shares — an estimated $1K sold.

Main Management first reported a position in LABU in Q4 2022 and held it in 4 quarters. The position peaked at $1K in Q2 2024. 43 funds tracked by Wall St. Rank hold LABU as of Q3 2024.

Main Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2024 after selling out during the quarter.
Main Management sold 5 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2024, an estimated $1K.
Main Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 4 quarters.
Main Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1K in Q2 2024.
43 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2024.

Based on Main Management's 13F filing for Q3 2024, filed 15 Nov 2024.